Vascular smooth muscle cells from small human omental arteries express P2X1 and P2X4 receptor subunits

[1]  O. Povstyan,et al.  Characterization of transcriptional and posttranscriptional properties of native and cultured phenotypically modulated vascular smooth muscle cells , 2013, Cell and Tissue Research.

[2]  M. Harhun,et al.  Resident phenotypically modulated vascular smooth muscle cells in healthy human arteries , 2012, Journal of cellular and molecular medicine.

[3]  L. Ren,et al.  P2X1 receptor-mediated pressor responses in the anesthetized mouse , 2012 .

[4]  V. Ralevic.  P2X receptors in the cardiovascular system , 2012 .

[5]  D. Gordienko,et al.  Ca2+ entry following P2X receptor activation induces IP3 receptor‐mediated Ca2+ release in myocytes from small renal arteries , 2011, British journal of pharmacology.

[6]  D. Gordienko,et al.  Purinoreceptor‐mediated current in myocytes from renal resistance arteries , 2010, British journal of pharmacology.

[7]  E. Inscho,et al.  P2X(1) receptor blockade inhibits whole kidney autoregulation of renal blood flow in vivo. , 2010, American journal of physiology. Renal physiology.

[8]  R. Marée,et al.  P2X1 Ion Channels Promote Neutrophil Chemotaxis through Rho Kinase Activation , 2009 .

[9]  T. Bolton,et al.  Interstitial cells from rat middle cerebral artery belong to smooth muscle cell type , 2008, Journal of cellular and molecular medicine.

[10]  J. Brock,et al.  ATP is the predominant sympathetic neurotransmitter in rat mesenteric arteries at high pressure , 2007, The Journal of physiology.

[11]  V. Ralevic,et al.  Raised tone reveals purinergic-mediated responses to sympathetic nerve stimulation in the rat perfused mesenteric vascular bed. , 2007, European journal of pharmacology.

[12]  T. Bolton,et al.  Role of intracellular stores in the regulation of rhythmical [Ca2+]i changes in interstitial cells of Cajal from rabbit portal vein. , 2006, Cell calcium.

[13]  G. Burnstock,et al.  P2X1 receptors are closely associated with connexin 43 in human ventricular myocardium. , 2005, International journal of cardiology.

[14]  A. Nicke,et al.  Biochemical and functional evidence for heteromeric assembly of P2X1 and P2X4 subunits , 2005, Journal of neurochemistry.

[15]  G. Schmalzing,et al.  NF449, a novel picomolar potency antagonist at human P2X1 receptors. , 2003, European journal of pharmacology.

[16]  D. Erlinge,et al.  Potent P2Y6 receptor mediated contractions in human cerebral arteries , 2003, BMC pharmacology.

[17]  E. Schwiebert,et al.  Sustained Calcium Entry through P2X Nucleotide Receptor Channels in Human Airway Epithelial Cells* , 2003, The Journal of Biological Chemistry.

[18]  R. North.  Molecular physiology of P2X receptors. , 2002, Physiological reviews.

[19]  G. Schmalzing,et al.  NF449: a subnanomolar potency antagonist at recombinant rat P2X1 receptors , 2001, Naunyn-Schmiedeberg's Archives of Pharmacology.

[20]  G. Schmalzing,et al.  The suramin analogue NF279 is a novel and potent antagonist selective for the P2X1 receptor , 2000, Neuropharmacology.

[21]  T. Egan,et al.  Hetero-oligomeric Assembly of P2X Receptor Subunits , 1999, The Journal of Biological Chemistry.

[22]  GervaiseLoirand,et al.  P2X7 Receptor Activation–Induced Contraction and Lysis in Human Saphenous Vein Smooth Muscle , 1998 .

[23]  G Burnstock,et al.  Pharmacological and histochemical evidence for P2X receptors in human umbilical vessels. , 1998, European journal of pharmacology.

[24]  G. Dubyak,et al.  The P2X1 receptor, an adenosine triphosphate-gated cation channel, is expressed in human platelets but not in human blood leukocytes. , 1998, Blood.

[25]  J. Firth,et al.  Pressure-induced myogenic responses in human isolated cerebral resistance arteries. , 1996, Stroke.

[26]  W. Stühmer,et al.  P2X4: an ATP-activated ionotropic receptor cloned from rat brain. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[27]  R. Evans,et al.  Vasoconstriction of guinea‐pig submucosal arterioles following sympathetic nerve stimulation is mediated by the release of ATP , 1992, British journal of pharmacology.

[28]  G. Burnstock.  Noradrenaline and ATP as cotransmitters in sympathetic nerves , 1990, Neurochemistry International.

[29]  G. Burnstock.  Local mechanisms of blood flow control by perivascular nerves and endothelium. , 1990, Journal of hypertension. Supplement : official journal of the International Society of Hypertension.

[30]  M. Mulvany,et al.  Structure and function of small arteries. , 1990, Physiological reviews.

[31]  A. Somlyo.  Excitation-contraction coupling and the ultrastructure of smooth muscle. , 1985, Circulation research.

[32]  O. Povstyan,et al.  Identification of functional P2X receptors in rat middle cerebral arteries. , 2013 .

[33]  Geoffrey Burnstock,et al.  Purinergic signalling , 2012, Acta physiologica.

[34]  A. Nicke,et al.  Monomeric and dimeric byproducts are the principal functional elements of higher order P2X1 concatamers. , 2003, Molecular pharmacology.

[35]  J. Huidobro-Toro,et al.  Pharmacological identification of P2X1, P2X4 and P2X7 nucleotide receptors in the smooth muscles of human umbilical cord and chorionic blood vessels. , 2003, Placenta.

[36]  G. Burnstock.  Purinergic nerves. , 1972, Pharmacological reviews.